EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study

Zhomart Orman iD, Jia Wei Koh iD, Caroline Trin, Zanfina Ademi iD, Ella Zomer iD, Danielle Berkovic iD, Jenni Ilomaki iD, J Simon Bell iD, Danny Liew iD, Christopher M Reid iD, Sean Lybrand, Brittany Schoeninger und 1 weitere

British Journal of Clinical Pharmacology · 2025

DOI: 10.1002/bcp.70170 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Zhomart Orman und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Primary Health Care, Hypolipidemic Agents, Cardiovascular Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to identify distinct trajectories of lipid‐modifying medication (LMM) persistence over time and to explore characteristics associated with each pattern.

Methods

Using primary care data from IQVIA, we conducted a retrospective cohort study of adults prescribed LMMs between January 2015 and December 2017, with 5 years of follow‐up. Persistence was defined as ≥1 prescription every 6 months. Group‐based trajectory modelling identified medication persistence patterns; characteristics were compared using 1‐way ANOVA and chi‐squared tests.

Results

Among 51 504 individuals (mean age 62 years, 53% male), 4 distinct trajectories were identified: persistent use (PU, 20%), gradual decline (10%), rapid decline (29%) and early discontinuation (41%). Compared to those who discontinued early, individuals in the rapid decline, gradual decline and PU groups were older by 1.18 (95% confidence interval: 0.82–1.55), 2.61 (2.08–3.13) and 3.71 (3.30–4.12) years, respectively. Persistent users were more likely to have cardiovascular risk factors: a higher proportion of smokers (44.4 vs . 39.6%), elevated systolic blood pressure (≥140 mmHg: 36.9 vs . 32.9%) and reduced renal function (estimated glomerular filtration rate >45 mL/min/m 2 : 14.4 vs . 11.7%) compared to those who discontinued LMMs early. In contrast, the early discontinuation group had a greater proportion of metropolitan residents (76.1 vs . 69.2%) and individuals with elevated total cholesterol ratios (>4: 60.8 vs . 53.8%) than the PU group.

Conclusions

Distinct profiles across trajectories highlight the need for tailored interventions to improve long‐term medication use, particularly among younger, healthier individuals and those residing in metropolitan areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Health CareHypolipidemic AgentsCardiovascular DiseasesHumansMaleRetrospective StudiesFemaleMiddle AgedAgedFollow-Up StudiesHeart Disease Risk FactorsAdult

Stichwörter der Autor:innen

group‐based trajectory analyseslipid‐modifying medicationsmedication persistenceprimary careprimary preventionstatins

Substanzen

Hypolipidemic Agents

Autor:innen und Institutionen

  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, VIC, Australia.
  • Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Brisbane, Australia.
  • School of Population Health, Curtin University, Perth, WA, Australia.
  • IQVIA Australia, St Leonards, NSW, Australia.

ORCID-Profile: Zhomart Orman, Jia Wei Koh, Zanfina Ademi, Ella Zomer, Danielle Berkovic, Jenni Ilomaki, J Simon Bell, Danny Liew, Christopher M Reid, Stella Talic

Förderung

  • Medical Research Future Fund

Zitieren

APA

Orman, Z., Koh, J. W., Trin, C., Ademi, Z., Zomer, E., Berkovic, D., Ilomaki, J., Bell, J. S., Liew, D., Reid, C. M., Lybrand, S., Schoeninger, B., & Talic, S. (2025). Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70170

Vancouver

Orman Z, Koh JW, Trin C, Ademi Z, Zomer E, Berkovic D, et al. Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study. British Journal of Clinical Pharmacology. 2025. doi:10.1002/bcp.70170

BibTeX
@article{Orman2025,
  author = {Orman, Zhomart and Koh, Jia Wei and Trin, Caroline and Ademi, Zanfina and Zomer, Ella and Berkovic, Danielle and Ilomaki, Jenni and Bell, J Simon and Liew, Danny and Reid, Christopher M and Lybrand, Sean and Schoeninger, Brittany and Talic, Stella},
  title = {Medication persistence trajectories among individuals prescribed lipid‐lowering therapy in primary care settings: A retrospective cohort study},
  journal = {British Journal of Clinical Pharmacology},
  year = {2025},
  doi = {10.1002/bcp.70170}
}
Kostenlos starten →